North Dakota: Saxenda litigation | DrugsMonitor.com

Saxenda litigation in North Dakota (ND): State-level court context, limitation talking points, attorney consult—not legal advice.

Liraglutide (Saxenda) is a GLP-1-class therapy; plaintiffs group gastrointestinal and related injury theories with broader GLP-1 litigation themes., North Dakota